Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: Expression, distribution, and calcium binding activity, The Prostate, vol.2, issue.3, pp.130-140, 2004. ,
DOI : 10.1002/pros.20054
The translationally controlled tumour protein (TCTP), The International Journal of Biochemistry & Cell Biology, vol.36, issue.3, pp.379-385, 2004. ,
DOI : 10.1016/S1357-2725(03)00213-9
A Knockout Mouse Approach Reveals that TCTP Functions as an Essential Factor for Cell Proliferation and Survival in a Tissue- or Cell Type-specific Manner, Molecular Biology of the Cell, vol.18, issue.7, pp.2525-2532, 2007. ,
DOI : 10.1091/mbc.E07-02-0188
Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src, Oncogene, vol.20, issue.19, pp.2264-2274, 2011. ,
DOI : 10.1038/onc.2010.604
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death, Experimental Cell Research, vol.317, issue.17, pp.2479-2489, 2011. ,
DOI : 10.1016/j.yexcr.2011.07.012
The molecular programme of tumour reversion: the steps beyond malignant transformation, Nature Reviews Cancer, vol.101, issue.3, pp.206-216, 2009. ,
DOI : 10.1038/nrc2589
Characterization of Fortilin, a Novel Antiapoptotic Protein, Journal of Biological Chemistry, vol.276, issue.50, pp.47542-47549, 2001. ,
DOI : 10.1074/jbc.M108954200
Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1, Proceedings of the National Academy of Sciences, vol.276, issue.50, pp.14976-14981, 2002. ,
DOI : 10.1074/jbc.M108954200
Translationally controlled tumor protein is a target of tumor reversion, Proceedings of the National Academy of Sciences, vol.16, issue.16, pp.15364-15369, 2004. ,
DOI : 10.1038/sj.onc.1201729
p53: structure, function and therapeutic applications, J Cancer Molecules, vol.2, pp.141-153, 2006. ,
Regulation of p53 by ING family members in suppression of tumor initiation and progression, Cancer and Metastasis Reviews, vol.291, issue.5, pp.55-73, 2012. ,
DOI : 10.1007/s10555-011-9329-5
Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence, Seminars in Cancer Biology, vol.21, issue.6, pp.367-376, 2011. ,
DOI : 10.1016/j.semcancer.2011.10.005
The Role of p53 in Metabolic Regulation, Genes & Cancer, vol.2, issue.4, pp.385-391, 2011. ,
DOI : 10.1177/1947601911409738
Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells, Cancer Letters, vol.314, issue.1, pp.8-23, 2012. ,
DOI : 10.1016/j.canlet.2011.09.040
Reciprocal repression between P53 and TCTP, Nature Medicine, vol.9, issue.1, pp.91-99, 2011. ,
DOI : 10.1073/pnas.0400177101
Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53, FEBS Letters, vol.95, issue.1, pp.29-35, 2011. ,
DOI : 10.1016/j.febslet.2010.11.014
Complex relationship between TCTP, microtubules and actin microfilaments regulates cell shape in normal and cancer cells, Carcinogenesis, vol.30, issue.4, pp.555-565, 2009. ,
DOI : 10.1093/carcin/bgp022
URL : https://hal.archives-ouvertes.fr/inserm-00365989
Identification of a cofilin-like actin-binding site on translationally controlled tumor protein (TCTP), FEBS Letters, vol.346, issue.23, pp.4756-4760, 2010. ,
DOI : 10.1016/j.febslet.2010.10.054
Actin-dependent Lamellipodia Formation and Microtubule-dependent Tail Retraction Control-directed Cell Migration, Molecular Biology of the Cell, vol.11, issue.9, pp.2999-3012, 2000. ,
DOI : 10.1091/mbc.11.9.2999
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC14971
Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells, Nature Cell Biology, vol.5, issue.9, pp.803-811, 2003. ,
DOI : 10.1038/ncb1037
Changes in Gene Expression and Cellular Architecture in an Ovarian Cancer Progression Model, PLoS ONE, vol.25, issue.3, p.17676, 2011. ,
DOI : 10.1371/journal.pone.0017676.s002
Intermediate Filaments in Ovarian Tumors, International Journal of Gynecological Pathology, vol.12, issue.2, pp.166-169, 1993. ,
DOI : 10.1097/00004347-199304000-00014
p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells, Oncogene, vol.127, issue.21, pp.2420-2432, 2011. ,
DOI : 10.1210/en.2005-1404
The effects of cancer progression on the viscoelasticity of ovarian cell cytoskeleton structures, Nanomedicine: Nanotechnology, Biology and Medicine, vol.8, issue.1, pp.93-102, 2012. ,
DOI : 10.1016/j.nano.2011.05.012
Cytokeratin expression correlates with aneuploidy in cytological specimens of melanoma metastases, Anticancer Res, vol.25, pp.2789-2792, 2005. ,
Cytokeratins in the histological diagnosis of malignant tumors, Int J Biol Markers, vol.9, pp.63-69, 1994. ,
SPARC Inhibits LPA-Mediated Mesothelial???Ovarian Cancer Cell Crosstalk, Neoplasia, vol.9, issue.1, pp.23-35, 2007. ,
DOI : 10.1593/neo.06658
URL : http://doi.org/10.1593/neo.06658
Pseudopodial Actin Dynamics Control Epithelial-Mesenchymal Transition in Metastatic Cancer Cells, Cancer Research, vol.70, issue.9, pp.3780-3790, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-4439
Correlative nanomechanical profiling with super-resolution F-actin imaging reveals novel insights into mechanisms of cisplatin resistance in ovarian cancer cells, Nanomedicine: Nanotechnology, Biology and Medicine, vol.8, issue.5, pp.757-766, 2012. ,
DOI : 10.1016/j.nano.2011.09.015
The epithelial polarity program: machineries involved and their hijacking by cancer, Oncogene, vol.10, issue.55, pp.6939-6957, 2008. ,
DOI : 10.1083/jcb.200502055
Epithelial???mesenchymal transition in ovarian cancer, Cancer Letters, vol.291, issue.1, pp.59-66, 2010. ,
DOI : 10.1016/j.canlet.2009.09.017
EMT, the cytoskeleton, and cancer cell invasion, Cancer and Metastasis Reviews, vol.20, issue.1, pp.15-33, 2009. ,
DOI : 10.1007/s10555-008-9169-0
Deacetylation of cortactin by SIRT1 promotes cell migration, Oncogene, vol.27, issue.3, pp.445-460, 2009. ,
DOI : 10.1038/onc.2008.388
Cancer Statistics, 2010, CA: A Cancer Journal for Clinicians, vol.60, issue.5, pp.277-300, 2010. ,
DOI : 10.3322/caac.20073
Activation of the p53 pathway induces ??-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages, Journal of Cellular Physiology, vol.73, issue.5, pp.1829-1837, 2012. ,
DOI : 10.1002/jcp.22910
A novel function for Cyclin A2: Control of cell invasion via RhoA signaling, The Journal of Cell Biology, vol.113, issue.1, pp.147-162, 2012. ,
DOI : 10.1074/jbc.M406082200
URL : https://hal.archives-ouvertes.fr/hal-00714616
Tumor Vesicle???Associated CD147 Modulates the Angiogenic Capability of Endothelial Cells, Neoplasia, vol.9, issue.4, pp.349-357, 2007. ,
DOI : 10.1593/neo.07133
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin, Journal of Clinical Investigation, vol.118, issue.4, pp.1367-1379, 2008. ,
DOI : 10.1172/JCI33775
Electron microscopy, immunostaining, cytoskeleton visualization, in situ hybridization, and three-dimensional reconstruction of Xenopus oocytes, Methods, vol.51, issue.1, pp.11-19, 2010. ,
DOI : 10.1016/j.ymeth.2009.12.003
Changes in Cytoskeletal Protein Composition Indicative of an Epithelial-Mesenchymal Transition in Human Micrometastatic and Primary Breast Carcinoma Cells, Clinical Cancer Research, vol.11, issue.22, pp.8006-8014, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-0632
Mechanisms of Motility in Metastasizing Cells, Molecular Cancer Research, vol.8, issue.5, pp.629-642, 2010. ,
DOI : 10.1158/1541-7786.MCR-10-0139
Comparative proteome analysis of human epithelial ovarian cancer, Proteome Science, vol.5, issue.1, p.16, 2007. ,
DOI : 10.1186/1477-5956-5-16
A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer, Molecular Endocrinology, vol.24, issue.2, pp.447-463, 2010. ,
DOI : 10.1210/me.2009-0295
Translationally controlled tumor protein is a conserved mitotic growth integrator in animals and plants, Proceedings of the National Academy of Sciences, vol.28, issue.2, pp.16384-16389, 2010. ,
DOI : 10.1002/1526-968X(200010)28:2<82::AID-GENE60>3.0.CO;2-Z
URL : https://hal.archives-ouvertes.fr/hal-00521824
Characterization of an N-terminally Truncated Cyclin A Isoform in Mammalian Cells, Journal of Biological Chemistry, vol.276, issue.32, pp.29987-29993, 2001. ,
DOI : 10.1074/jbc.M005452200
Do truncated cyclins contribute to aberrant cyclin expression in cancer? Cell Cycle, pp.472-477, 2006. ,
Cyclin A Is Redundant in Fibroblasts but Essential in Hematopoietic and Embryonic Stem Cells, Cell, vol.138, issue.2, pp.352-365, 2009. ,
DOI : 10.1016/j.cell.2009.04.062
Early Development of Mouse Embryos Null Mutant for the Cyclin A2 Gene Occurs in the Absence of Maternally Derived Cyclin A2 Gene Products, Developmental Biology, vol.223, issue.1, pp.139-153, 2000. ,
DOI : 10.1006/dbio.2000.9721